Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 18, 2008Journal of Antimicrobial ChemotherapyOpen Access

Treatment of acute hepatitis C: the success of monotherapy with (pegylated) interferon  

View Full Paper
Ask AI
Bookmark
Share

Authors

JWJohannes WiegandLeipzig UniversityKDKatja DeterdingMedizinische Hochschule HannoverMCMarkus CornbergMedizinische Hochschule Hannover

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Wiegand et al. (2008) studied this question.

synapsesocial.com/papers/6a76115b4b4bbb4785fbd817https://doi.org/10.1093/jac/dkn346
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Treatment of acute hepatitis C with interferon α‐2b: early initiation of treatment is the most effective predictive factor of sustained viral response2004 · 57 citations
  2. 2Epidemiological characteristics and medical follow-up of 61 patients with acute hepatitis C identified through the hepatitis C surveillance system in France2007 · 11 citations
  3. 3Pegylated interferon alfa and ribavirin for 14 versus 24 weeks in patients with hepatitis C virus genotype 2 or 3 and rapid virological response2007 · 209 citations
  4. 4Peginterferon-α2a and Ribavirin Combination Therapy in Chronic Hepatitis C2004 · 2,841 citations